Results 41 to 50 of about 232,449 (132)

Novel Germline RUNX1 Mutation Associated with Familial Thrombocytopenia as well as B-Acute Lymphoblastic Leukemia: A Case Report and Review of the Literature

open access: yesCase Reports in Oncology, 2021
Germline RUNX1 mutations lead to a rare form of autosomal-dominant familial thrombocytopenia with a predisposition for myeloid malignancies and are classified as distinct entities by the WHO.
Nabin Karki   +2 more
doaj   +1 more source

23rd Congress of the European Hematology Association Stockholm, Sweden, June 14‐17, 2018

open access: yes, 2018
HemaSphere, Volume 2, Issue S1, Page 1-1113, June 2018.
wiley   +1 more source

Accurate automated diagnosis of B-acute lymphoblastic leukemia using deep learning and flow cytometry

open access: yesHaematologica
Not available.
Sulov Chalise   +8 more
doaj   +1 more source

A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia [PDF]

open access: yes, 2010
Background: Abnormalities of 11q23 involving the MLL gene are found in approximately 10% of human leukemias. To date, nearly 100 different chromosome bands have been described in rearrangements involving 11q23 and 64 fusion genes have been cloned and ...
Meyer, Claus   +32 more
core   +2 more sources

Funkcionális genomikai rendszer kidolgozása gyermekkori acut lymphoid leukémiában DNS és cDNS chip analízis valamint immunfenotipizálás alapján = Development of a novel functional genomic system in pediatric acute lymphoid leukemia based on DNA and cDNA chip analysis as well as immunophenotyping [PDF]

open access: yes, 2007
Olyan molekuláris markerek genomikai identifikálását tűztük ki célul, melyek a gyermekkori akut limfoid leukémia (ALL) patomechanizmusának felderítésében, osztályzásának pontosításában és a kezelésre adott válasz predikciójában szerepet játszhatnak.
Falus, András   +4 more
core   +1 more source

Unveiling the omics tapestry of B-acute lymphoblastic leukemia: bridging genomics, metabolomics, and immunomics

open access: yesScientific Reports
Acute B-lymphoblastic leukemia (B-ALL) is a highly heterogeneous hematologic malignancy, characterized by significant molecular differences among patients as the disease progresses.
Yin Le   +3 more
doaj   +1 more source

Post-Induction Remission Status in B-Acute Lymphoblastic Leukemia Patients (B-ALL),  Experience at Tertiary Care Hospital

open access: yesPakistan Armed Forces Medical Journal
Objectives: To determine the frequency of post-induction remission status and its association with cytogenetic and molecular abnormalities in patients with B-ALL. Study Design: Cross-sectional Analytical study.
Sumaira Ilyas   +5 more
doaj   +1 more source

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I [PDF]

open access: yes, 2012
Background: Chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphatic leukemia (Ph + ALL) are caused by the t(9;22), which fuses BCR to ABL resulting in deregulated ABL-tyrosine kinase activity.
Ruimi, Nili   +18 more
core   +2 more sources

Minimal residual disease detection in Tunisian B-acute lymphoblastic leukemia based on immunoglobulin gene rearrangements

open access: yesBrazilian Journal of Medical and Biological Research
IGH gene rearrangement and IGK-Kde gene deletion can be used as molecular markers for the assessment of B lineage acute lymphoblastic leukemia (B-ALL).
S. Besbes   +8 more
doaj   +1 more source

MTHFR Polymorphisms In Childhood Acute lymphoblastic Leukemia: Influence On Methotrexate Therapy [PDF]

open access: yes, 2017
Methotrexate (MTX) is an important component in the therapy used to treat childhood acute lymphoblastic leukemia (ALL). Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme for MTX pharmacokinetics.
Gutiérrez Camino, Ángela   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy